VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ABLLL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
$25.61$2.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksABLLLBalance Sheet

Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) Balance Sheet

5Y historyFree accessUpdated daily

Total assets expanded to $918.9 million by 2025Q3, while the firm's reliance on external financing is reflected in a debt-to-equity ratio of 0.28 and rising claims payments of $7.7 million.

ABLLL Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'24Dec'23Dec'22Dec'21Dec'20
Total Assets918.94M874.16M331.83M59.09M1.84M1.46M
Asset Growth %454.21%163.44%461.51%3111.3%25.94%-
Total Investment Assets4M375.54M129.1M3.19M1.5M1.25M
Long-Term Investments1.25B375.54M126.85M3.19M1.5M1.25M
Short-Term Investments002.25M000
Total Current Assets138.15M159.56M31.78M33.28M194.82K211.2K
Cash & Equivalents86.42M131.94M25.59M30.05M102.42K135.27K
Receivables98.63M26.53M3.24M208.81K00
Other Current Assets21.34M1.09M699.13K2.9M67.49K74.76K
Goodwill & Intangibles1.26B318.08M169.91M000
Goodwill248.96M238.3M140.29M000
Intangible Assets70.49M79.79M29.62M000
PP&E (Net)6.31M5.75M2.29M95.63K145.4K0
Other Assets445.18M15.23M998.95K22.53M00
Total Liabilities479.34M450.87M167.76M30.95M1.07M160.7K
Total Debt124.71M385.91M141.74M28.59M1.05M148.97K
Net Debt38.29M253.97M116.15M-1.46M950.71K13.7K
Long-Term Debt4.54M342.39M126.79M28.25M00
Short-Term Debt120.17M38.43M13.03M263.79K930.63K148.97K
Total Current Liabilities148.44M62.47M23.33M1.3M995.93K160.7K
Accounts Payable00040.01K00
Deferred Revenue02.47M507K000
Other Current Liabilities28.27M14.42M3.4M950.48K20.19K11.73K
Deferred Taxes114.61M1000K1000K000
Other Liabilities295.13M14.66M6.64M1.36M00
Total Equity439.59M423.29M164.07M28.15M766.89K1.3M
Equity Growth %455.98%158%482.85%3570.62%-41.03%-
Shareholders Equity439.59M424.15M163.93M27.25M915.05K1.3M
Minority Interest0-857.83K138.28K899.54K-148.16K0
Retained Earnings0-57.9M-34.73M25.49M205.05K590.5K
Common Stock010.13K6.34K5.04K50K50K
Accumulated OCI00108.37K1.05M00
Return on Equity (ROE)2.51%-8.16%9.9%219.13%96.49%50.91%
Return on Assets (ROA)1.2%-3.97%4.87%103.99%60.42%45.31%
Equity / Assets47.84%48.42%49.44%47.63%41.67%89%
Debt / Equity0.28x0.91x0.86x1.02x1.37x0.11x
Book Value per Share4.555.982.840.950.020.03
Tangible BV per Share1.241.49-0.100.950.020.03

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetStrained
Cash FlowBurning
Top Statement Risk

Fair value accounting volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2025Q3)

Rapid Asset Expansion Outpacing Capital

As reported in recent financial statements, Abacus Life has aggressively expanded its total assets from $277.3 million in 2023Q2 to $918.9 million in 2025Q3, a trajectory that suggests a rapid scaling of the policy portfolio that significantly outpaces the company's internal capital generation capabilities.

The rapid growth in total assets appears to be driven by the acquisition of life settlement contracts, which necessitates substantial upfront cash outlays. Investors should monitor whether this asset accumulation is sustainable given the concurrent increase in liabilities, which have risen to $479.3 million over the same period.

Leverage Pressures Amid Portfolio Scaling

Based on the provided balance sheet data, the company's equity base has grown to $439.6 million as of 2025Q3, yet the rising liability profile suggests that the firm is increasingly reliant on external financing to support its aggressive policy acquisition strategy and maintain its current growth trajectory.

The expansion of the balance sheet indicates that management is prioritizing market share over immediate capital preservation. This approach may leave the firm vulnerable to shifts in credit market conditions, as the reliance on debt to fund policy premiums and acquisitions creates a structural sensitivity to interest rate volatility.

Rising Claims Reflect Portfolio Maturation

According to historical data, claims payments have trended upward from $973.4 thousand in 2023Q2 to $7.7 million in 2025Q3, which indicates the natural maturation of the life settlement portfolio and the increasing cash requirements associated with the firm's growing base of held policies.

The upward trend in claims payments is a natural consequence of a growing portfolio, but it also highlights the persistent cash outflow requirements inherent in the business model. Analysts should evaluate whether the current reserve levels are sufficient to cover future obligations without necessitating further capital raises.

Accounting Volatility Masks Liquidity Risks

As indicated by the discrepancy between net income and operational performance, the reliance on ASC 820 fair value accounting may be masking the true liquidity profile of the firm, as non-cash unrealized gains often drive headline earnings while mandatory premium payments represent a persistent cash outflow.

The reliance on fair value adjustments creates a disconnect between reported accounting figures and the actual cash movement required to sustain operations. Investors should be cautious, as the volatility in these non-cash adjustments may obscure the underlying cash burn associated with maintaining the life settlement portfolio.

ABLLL — Frequently Asked Questions

Quick answers to the most common questions about buying ABLLL stock.

What are the total assets of Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL)?

As of 2024, Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) had total assets of $874.2M including $159.6M in current assets.

How much debt does Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) have?

Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) carries total debt of $385.9M, offset by $131.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028?

Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) has total shareholders' equity (book value) of $424.2M ($5.98 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's current ratio and liquidity?

Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) reported a current ratio of 2.55x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.